Fingerprint
Dive into the research topics of 'A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancer
John J. Kavanagh, Larry J. Copeland, David M. Gershenson, Patton B. Saul, Creighton L. Edwards
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations